News | March 30, 2008

TEE Offers Real-Time 3D in the Cath Lab

March 31, 2008 - As part of the Philips cath lab showcase at ACC, the company presented Live 3D TEE technology for the cath lab, designed to give real-time volume rendered images using one-touch controls.

Live 3D TEE is said to be capable of imaging catheters, devices and adjacent structures simultaneously, giving users access to more data for planning, increased visualization during guided procedures

The company also featured the Allura Xper features solutions for diagnostic, interventional and pediatric cardiology, as well as vascular interventions and electrophysiology. This 3D-coronary angiography tool reportedly aim to simplify 3D modeling of the coronary arteries in adults with CAD, and can help avoid foreshortening of lesions so that interventionalists can choose the correct length stent, reducing stent costs, according to the company. The rotational angiography technology has been shown to reduce average total patient X-ray exposure and contrast utilization by approximately 30 percent each compared to standard angiography.

The StentBoost works to improve visualization of stents and contrast agents in the coronary arteries. With the ability to transfer CT volumes from the Brilliance CT to the Allura Xper systems, CT TrueView provides an additional way for interventionalists to quickly select the proper projection angle to avoid foreshortening.

For more information: www.medical.philips.com

Related Content

Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable| September 08, 2017 | Dave Fornell
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular s
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
News | Stents Drug Eluting| September 01, 2017
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init